Ben Schwartz
Ben Schwartz is Associate Editor, Contemporary OB/GYN.
Study: Early-term births linked to poorer CRF through young adulthood
Longitudinal data from a prospective cohort study indicate that being born early term may negatively affect a child’s cardiorespiratory fitness. Plus: Is there a difference in PTB rate between branded and compounded 17P? Also, a review analyzes whether or not there are any benefits to placentophagy.
Meta-analysis on oocyte donation and perinatal outcomes
A systematic review and meta-analysis suggests that in pregnancies conceived via assisted reproduction, risk of adverse perinatal outcomes may be higher with donated than with autologous oocytes. Plus: Do post-cesarean antibiotics reduce infections in obese women? Also: Researchers believe they have identified the genes associated with preterm delivery.
Study: Annual ob/gyn visits declining
Researchers note that the number of women who annually visit an ob/gyn has steadily declined since 2000. Plus: MAb may reduce risk of fracture in women with osteoporosis. Also, a study shows that postmenopausal hormone therapy is not associated with risk of all-cause, cardiovascular, or total cancer mortality.
How effective is the 9-valent HPV vaccine?
One study looks at how successful the 9vHPV vaccine is in preventing HPV-related cervical, vaginal, and vulvar diseases. Plus: FDA approves first neonatal MRI. Also, researchers note that obstetric services in rural areas severely lacking.
Uro Pipeline: Supplemental application submitted for advanced RCC treatment
Other pipeline developments include an agent to control pain in IC/BPS patients, an antibody to treat prostate and bladder cancer, an injectable OAB treatment, and more.
New products: Holmium laser increases stone ablation volume
Other products discussed include cancer tests, an app to connect patients with specialists, a revenue management system, and more
Uro Pipeline: Phase IIb study begins for intraprostatic localized PCa drug
Other pipeline developments include a new company formed to develop OAB treatments, a phase III urothelial cancer study meeting its primary endpoint, the formation of a partnership to study RCC treatment, and more.
New Products: Nasal spray to treat nocturia receives FDA approval
Other products discussed include catheter sets to make the ordering process easier, a micro-US/MRI fusion application for prostate imaging, an international prostate registry for HIFU and more.
Uro Pipeline: FDA accepts two supplemental applications for mUC agent
Other pipeline developments include efficacy results for a bladder and prostate cancer drug, an infertility tool to predict sperm quality, the initiation of an immunotherapy combination for mUC, and more.
New Products: Two-in-one wire device combines access, safety guides
Other products discussed include an updated prostate tissue ablation device, a contrast agent for voiding ultrasonography, a bladder cancer test and more.

Poll

View Results